Anna Csiszar to Administration, Oral
This is a "connection" page, showing publications Anna Csiszar has written about Administration, Oral.
Connection Strength
0.074
-
Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial. J Pharmacol Exp Ther. 2025 Jul; 392(7):103607.
Score: 0.058
-
Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance. Pharmacol Rep. 2007 Jul-Aug; 59(4):428-36.
Score: 0.017